NEW YORK (GenomeWeb News) – University of North Carolina at Chapel Hill researchers have won a $2.4 million grant to study genetic variations in diabetes patients in order to predict response to treatment and reduce cardiovascular disease, UNC said Monday.

Funded by the National Heart, Lung, and Blood Institute, the four-year study will be led by the North Carolina Translational and Clinical Sciences Institute, which is the academic home of the National Institutes of Health's Clinical and Translational Science Award at UNC.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.

Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.

Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.

Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.